{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:50:54Z","timestamp":1793523054276,"version":"4.5.0"},"reference-count":185,"publisher":"California Digital Library (CDL)","issue":"4","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WestJEM"],"DOI":"10.5811\/westjem.2019.5.42650","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:46:29Z","timestamp":1562679989000},"page":"587-600","source":"Crossref","is-referenced-by-count":69,"title":["Evaluation and Management of Angioedema in the Emergency Department"],"prefix":"10.5811","volume":"20","author":[{"given":"Brit","family":"Long","sequence":"first","affiliation":[{"name":"Brooke Army Medical Center, Department of Emergency Medicine, Fort Sam Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[{"name":"The University of Texas Southwestern Medical Center, Department of Emergency Medicine, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Department of Emergency Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"29705","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014;21(4):469\u201384.","DOI":"10.1111\/acem.12341"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bork K. An evidence based therapeutic approach to hereditary and acquired angioedema. Curr Opin Allergy Clin Immunol. 2014;14(4):354-62.","DOI":"10.1097\/ACI.0000000000000082"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Bork K. Angioedema. Immunol Allergy Clin North Am. 2014;34(1):23-31.","DOI":"10.1016\/j.iac.2013.09.004"},{"key":"ref3","unstructured":"Wilkerson RG. Angioedema in the emergency department: an evidence-based review. Emerg Med Pract. 2012;14(11): 1-21."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Frigas E, Nzeako UC. Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol. 2002;23(2):217-3.","DOI":"10.1385\/CRIAI:23:2:217"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kim SJ, Brooks JC, Sheikh J, et al. Angioedema deaths in the United States, 1979-2010. Ann Allergy Asthma Immunol. 2014;113(6):630-4.","DOI":"10.1016\/j.anai.2014.09.003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med. 2012;5(1):39.","DOI":"10.1186\/1865-1380-5-39"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bernstein JA, Cremonsei P, Hoffman TK, et al. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med.\u00a02017;10(1):15.","DOI":"10.1186\/s12245-017-0141-z"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gill P, Betschel SD. The clinical evaluation of angioedema. Immunol Allergy Clin N Am. 2017;37(3):449-66.","DOI":"10.1016\/j.iac.2017.04.007"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Gaeta TJ, Clark S, Pelletier AJ, et al. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol. 2007;98(4):360-5.","DOI":"10.1016\/s1081-1206(10)60883-6"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zilberberg MD, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc. 2010;31(6):511-9.","DOI":"10.2500\/aap.2010.31.3403"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Lin RY, Anderson AS, Shah SN, et al. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol. 2008;101(4):387-93.","DOI":"10.1016\/s1081-1206(10)60315-8"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-36.","DOI":"10.1056\/NEJMcp0803977"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Bas M, Adams V, Suvorava T, et al. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842-56.","DOI":"10.1111\/j.1398-9995.2007.01427.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bernstein JA. Update on angioedema: evaluation, diagnosis, and treatment. Allergy Asthma Proc. 2011;32(6):408-12.","DOI":"10.2500\/aap.2011.32.3469"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327-32.","DOI":"10.1016\/s1081-1206(10)60594-7"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692-7.","DOI":"10.1016\/j.jaci.2012.05.055"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Bork K. Recurrent angioedema and the threat of asphyxiation. Dtsch Arztebl Int. 2010;107(23):408-14.","DOI":"10.3238\/arztebl.2010.0408"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Craig T, Pursun EA, Bork K, et al. WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J. 2012;5(12):182-99.","DOI":"10.1097\/wox.0b013e318279affa"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hoyer C, Hill MR, Kaminski ER. Angio-oedema: an overview of differential diagnosis and clinical management. Contin Educ Anaesth Crit Care Pain. 2012;12(6):307-11.","DOI":"10.1093\/bjaceaccp\/mks036"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Bluestein HM, Hoover TA, Banerji AS, et al. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol. 2009;103(6):502-7.","DOI":"10.1016\/s1081-1206(10)60267-0"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Bernstein JA, Moellman JJ. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Postgrad Med. 2012;124(3):91-100.","DOI":"10.3810\/pgm.2012.05.2552"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lang DM, Aberer W, Bernstein JA, et al. International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol. 2012;109(6):395-402.","DOI":"10.1016\/j.anai.2012.10.008"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Moellman JJ, Bernstein JA. Diagnosis and management of hereditary angioedema: an emergency medicine perspective. J Emerg Med. 2012;43(2):391-400.","DOI":"10.1016\/j.jemermed.2011.06.125"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Ghably J, Saleh H, Vyas H, et al. Paul Ehrlich\u2019s mastzellen: a historical perspective of relevant developments in mast cell biology. Methods Mol Biol. 2015;1220:3-10.","DOI":"10.1007\/978-1-4939-1568-2_1"},{"key":"ref25","unstructured":"Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol. 2006;315:13-34."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Krishnaswamy G, Kelley J, Johnson D, et al. The human mast cell: functions in physiology and disease. Front Biosci. 2001;6:D1109-27.","DOI":"10.2741\/a673"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Grigoriadou S, Longhurst HJ. Clinical Immunology Review Series: an approach to the patient with angio-oedema. Clin Exp Immunol. 2008;155(3):367-77.","DOI":"10.1111\/j.1365-2249.2008.03845.x"},{"key":"ref28","unstructured":"Abbas AK, Pober JS, Lichtman AH. (2010). Cellular and Molecular Immunology, 2nd ed. Philadelphia, Pennsylvania: Saunders\/Elsevier."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Morgan BP. Hereditary angioedema-therapies old and new. N Engl J Med. 2010;363(6):581-3.","DOI":"10.1056\/NEJMe1006450"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Saleh H, Embry S, Nauli A, et al. Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution. Clin Mol Allergy. 2012;10(1):5.","DOI":"10.1186\/1476-7961-10-5"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Miller CW, Guha B, Krishnaswamy G. Exercise-induced anaphylaxis: a serious but preventable disorder. Phys Sportsmed. 2008;36(1):87-94.","DOI":"10.3810\/psm.2008.12.16"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Ismail S, Cheng L, Grigoriadou S, et al. Lesson of the month 2: the limitations of steroid therapy in bradykinin-mediated angioedema attacks. Clin Med (Lond). 2015;15(1):101-3.","DOI":"10.7861\/clinmedicine.15-1-101"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lawlor F, Black AK, Breathnach AS, et al. Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol. 1989;120(1):93-9.","DOI":"10.1111\/j.1365-2133.1989.tb07770.x"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Rose RF, Bhushan M, King CM, et al. Solar angioedema: an uncommonly recognized condition? Photodermatol Photoimmunol Photomed. 2005;21(5):226-8.","DOI":"10.1111\/j.1600-0781.2005.00175.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bentley B 2nd. Cold-induced urticaria and angioedema: diagnosis and management. Am J Emerg Med. 1993;11(1):43-6.","DOI":"10.1016\/0735-6757(93)90058-J"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Cicardi M, Zingale L, Zanichelli A, et al. C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol. 2005;27(3):286-98.","DOI":"10.1007\/s00281-005-0001-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Maurer M, Bader M, Bas MB, et al. New topics in bradykinin research. Allergy. 2011;66(11):1397-406.","DOI":"10.1111\/j.1398-9995.2011.02686.x"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Kaplan AP, Joseph K. Complement, kinins, and hereditary angioedema: mechanisms of plasma instability when C1 inhibitor is absent. Clin Rev Allergy Immunol. 2016;51(2):207-15.","DOI":"10.1007\/s12016-016-8555-6"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(3):193-204.","DOI":"10.1016\/j.anai.2010.01.007"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Kaplan AP, Joseph K. Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade. Immunol Allergy Clin North Am. 2017;37(3):513-25.","DOI":"10.1016\/j.iac.2017.04.001"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Gompels MM, Lock RJ, Morgan JE, et al. A multicentre study of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol. 2002;55(2):145-7.","DOI":"10.1136\/jcp.55.2.145"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Tarzi MD, Hickey A, Forster T, et al. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol. 2007;149(3):513-6.","DOI":"10.1111\/j.1365-2249.2007.03438.x"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Gang C, Lindsell CJ, Moellman J, et al. Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema. Allergy Asthma Proc. 2013;34(3):267-73.","DOI":"10.2500\/aap.2013.34.3664"},{"key":"ref44","unstructured":"Holm JP, Ovesen T. Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema. Dan Med J. 2012;59(6):A4449."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Williams-Johnson JA, Hemmings S, Williams EW, et al. Six years experience of angioedema at the University Hospital of the West Indies. West Indian Med J. 2007;56(3):278-81.","DOI":"10.1590\/s0043-31442007000300018"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Brown NJ, Ray WA, Snowden M, et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60(1):8-13.","DOI":"10.1016\/s0009-9236(96)90161-7"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol. 1980;116(8):902-5.","DOI":"10.1001\/archderm.1980.01640320052013"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Nussberger J, Cugno M, Amstutz C, et al. Plasma bradykinin in angio-oedema. Lancet. 1998;351(9117):1693-7.","DOI":"10.1016\/s0140-6736(97)09137-x"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Miller DR, Oliveria SA, Berlowitz DR, et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51(6):1624-30.","DOI":"10.1161\/hypertensionaha.108.110270"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Lin RY, Levine RJ, Lin H. Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009. Allergy Asthma Proc. 2013;34(1):65-71.","DOI":"10.2500\/aap.2013.34.3618"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637-42.","DOI":"10.1001\/archinte.165.14.1637"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006;26(4):725-37.","DOI":"10.1016\/j.iac.2006.08.001"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Blanch A, Roche O, Urrutia I, et al. First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol. 2006;118(6):1330-5.","DOI":"10.1016\/j.jaci.2006.07.035"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-74.","DOI":"10.1016\/j.amjmed.2005.09.064"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Berges-Gimeno MP, Martin-Lazaro J. Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better? Curr Allergy Asthma Rep. 2007;7(1):35-40.","DOI":"10.1007\/s11882-007-0028-9"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Zuraw BL, Christiansen SC. Pathophysiology of hereditary angioedema. Am J Rhinol Allergy. 2011;25(6):373-8.","DOI":"10.2500\/ajra.2011.25.3661"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Frazer-Abel A, Giclas PC. Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema. Allergy Asthma Proc. 2011;32(Suppl 1):S17-21.","DOI":"10.2500\/aap.2011.32.3472"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Yamamoto T, Horiuchi T, Miyahara H, et al. Hereditary angioedema in Japan: genetic analysis of 13 unrelated cases. Am J Med Sci. 2012;343(3):210-4.","DOI":"10.1097\/MAJ.0b013e31822bdb65"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Warin RP, Cunliffe WJ, Greaves MW, et al. Recurrent angioedema: familial and oestrogen-induced. Br J Dermatol. 1986;115(6):731-4.","DOI":"10.1111\/j.1365-2133.1986.tb06656.x"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Bork K, Barnstedt SE, Koch P, et al. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225):213-7.","DOI":"10.1016\/s0140-6736(00)02483-1"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Binkley KE, Davis A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106(3):546- 50.","DOI":"10.1067\/mai.2000.108106"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Prematta MJ, Kemp JG, Gibbs JG, et al. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc. 2009;30(5):506-11.","DOI":"10.2500\/aap.2009.30.3279"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Baeza ML, Rodriguez-Marco A, Prieto A, et al. Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III. Allergy. 2011;66(7):981-2.","DOI":"10.1111\/j.1398-9995.2011.02562.x"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Caldwell JR, Ruddy S, Schur PH, et al. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1972;1(1):39-52.","DOI":"10.1016\/0090-1229(72)90006-2"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Jackson J, Sim RB, Whelan A, et al. An IgG autoantibody which inactivates C1-inhibitor. Nature. 1986;323(6090):722-4.","DOI":"10.1038\/323722a0"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Chevailler A, Arlaud G, Ponard D, et al. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol. 1996;97(4):998-1008.","DOI":"10.1016\/s0091-6749(96)80076-5"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"D\u2019Incan M, Tridon A, Ponard D, et al. Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant? Dermatology. 1999;199(3):227-30.","DOI":"10.1159\/000018252"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Busse PJ. Angioedema: differential diagnosis and treatment. Allergy Asthma Proc. 2011;32(Suppl 1):3-11.","DOI":"10.2500\/aap.2011.32.3464"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Cicardi M, Zingale LC, Pappalardo E, et al. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore). 2003;82(4):274-81.","DOI":"10.1097\/01.md.0000085055.63483.09"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Fremeaux-Bacchi V, Guinnepain MT, Cacoub P, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med. 2002;113(3):194-9.","DOI":"10.1016\/s0002-9343(02)01124-5"},{"key":"ref71","unstructured":"Bertazzoni G, Spina MT, Scarpellini MG, et al. Drug-induced angioedema: experience of Italian emergency departments. Intern Emerg Med. 2014;9(4):455-62."},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Toh S, Reichman ME, Houstoun M, et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med. 2012;172(20):1582-9.","DOI":"10.1001\/2013.jamainternmed.34"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Strom BL, Carson JL, Morse ML, et al. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1987;30(10):1142-8.","DOI":"10.1002\/art.1780301009"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Settipane GA. Aspirin and allergic diseases: a review. Am J Med. 1983;74(6A):102-9.","DOI":"10.1016\/0002-9343(83)90537-5"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Beavers CJ, Dunn SP, Macaulay TE. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother. 2011;45(4):520-4.","DOI":"10.1345\/aph.1p630"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Kidney Disease Outcomes Quality Initiative (K\/DOQI). K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(Suppl 1):S1-290.","DOI":"10.1053\/j.ajkd.2004.03.003"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Bas M, Greve J, Strassen U, et al. Angioedema induced by cardiovascular drugs: new players join old friends. Allergy. 2015;70(10):1196-200.","DOI":"10.1111\/all.12680"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Bezalel S, Mahlab-Guri K, Asher I, et al. Angiotensin converting enzyme inhibitor-induced angioedema. Am J Med. 2015;128(2):120-5.","DOI":"10.1016\/j.amjmed.2014.07.011"},{"key":"ref79","unstructured":"Ba\u015f M, Hoffmann TK, Kojda G. Icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372(19):1867-8."},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Sala-Cunill A, Bj\u00f6rkqvist J, Senter R, et al. Plasma contact system activation drives anaphylaxis in severe mast cell mediated allergic reactions. J Allergy Clin Immunol. 2015;135(4):1031-43.e6.","DOI":"10.1016\/j.jaci.2014.07.057"},{"key":"ref81","unstructured":"US Hereditary Angioedema Association. Comprehensive angioedema typology and description. Available at: http:\/\/www.haea.org\/professionals\/angioedema\/.  Accessed November 3, 2015."},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602-16.","DOI":"10.1111\/all.12380"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175(9):1065-70.","DOI":"10.1503\/cmaj.060535"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Ishoo E, Shah UK, Grillone GA, et al. Predicting airway risk in angioedema: staging system based on presentation. Otolaryngol Head Neck Surg. 1999;121(3):263-8.","DOI":"10.1016\/s0194-5998(99)70182-8"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997;23(7):793-6.","DOI":"10.1007\/s001340050413"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Al-Khudari S, Loochtan MJ, Peterson E, et al. Management of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2011;121(11):2327-34.","DOI":"10.1002\/lary.22349"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Gannon TH, Eby TL. Angioedema from angiotensin converting enzyme inhibitors: a cause of upper airway obstruction. Laryngoscope. 1990;100(11):1156-60.","DOI":"10.1288\/00005537-199011000-00004"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"McCormick M, Folbe AJ, Lin HS, et al. Site involvement as a predictor of airway intervention in angioedema. Laryngoscope. 2011;121(2):262-6.","DOI":"10.1002\/lary.21277"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med. 1993;11(4):350-4.","DOI":"10.1016\/0735-6757(93)90166-9"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Saxena S, Gierl B, Eibling DE. Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope. 2010;120(1):62-4.","DOI":"10.1002\/lary.20683"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Stojiljkovic L. Renin-angiotensin system inhibitors and angioedema: anesthetic implications. Curr Opin Anaesthesiol. 2012;25(3):356-62.","DOI":"10.1097\/ACO.0b013e328352dda5"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Bork K, Staubach P, Eckardt AJ, et al. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101(3):619-27.","DOI":"10.1111\/j.1572-0241.2006.00492.x"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Khan DA. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis. Allergy Asthma Proc. 2011;32(1):1-10.","DOI":"10.2500\/aap.2011.32.3411"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Champion RH, Roberts SO, Carpenter RG, et al. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol. 1969;81(8):588-97.","DOI":"10.1111\/j.1365-2133.1969.tb16041.x"},{"key":"ref95","unstructured":"Vazquez Nava F, Almeida Arvizu VM, Sanchez Nuncio HR, et al. [Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico]. [Article in Spanish]. Rev Alerg Mex. 2004;51(5):181-8."},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Lenschow M, Bas M, Johnson F, et al. A score for the differential diagnosis of bradykinin- and histamine-induced head and neck swellings. Eur Arch Otorhinolaryngol. 2018;275(7):1767-73.","DOI":"10.1007\/s00405-018-4989-1"},{"key":"ref97","unstructured":"Calbo L, Quattrocchi P, Ferlazzo B. Abdominal attack of hereditary angioedema associated with marked leucocytosis. A case report. Ital J Gastroenterol. 1992;24(8):464-5."},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Zuraw BL, Bernstein JA, Lang DM, et al. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2013;131(6):1491-3.","DOI":"10.1016\/j.jaci.2013.03.034"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Markovic SN, Inwards DJ, Phyliky RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med. 2000;133(10):839.","DOI":"10.7326\/0003-4819-133-10-200011210-00025"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Li H, Busse P, Lumry WR, et al. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema. J Allergy Clin Immunol Pract. 2015;3(2):200-5.","DOI":"10.1016\/j.jaip.2014.08.002"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24.","DOI":"10.1186\/1710-1492-6-24"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Alsenz, J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med. 1987;316(22):1360-6.","DOI":"10.1056\/nejm198705283162202"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Scheirey CD, Scholz FJ, Shortsleeve MJ, et al. Angiotensin-converting enzyme inhibitor-induced small-bowel angioedema: clinical and imaging findings in 20 patients. AJR Am J Roentgenol. 2011;197(2):393-8.","DOI":"10.2214\/ajr.10.4451"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Jaiganesh T, Wiese M, Hollingsworth J, et al. Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med. 2013;20(1):10-7.","DOI":"10.1097\/MEJ.0b013e328356f76e"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Sofia S, Casali A, Bolondi L. Sonographic findings in abdominal hereditary angioedema. J Clin Ultrasound. 1999;27(9):537- 40.","DOI":"10.1002\/(sici)1097-0096(199911\/12)27:9<537::aid-jcu9>3.0.co;2-l"},{"key":"ref106","unstructured":"Walls R, Murphy M. (2012). Manual of Emergency Airway Management. Philadelphia, PA: Lippincott, Williams, and Wilkins, Wolters Kluwer."},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Kramer A, M\u00fcller D, Pf\u00f6rtner R, et al. Fibreoptic vs\u00a0videolaryngoscopic (C-MAC(\u00ae) D-BLADE) nasal awake intubation under local\u00a0anaesthesia. Anaesthesia. 2015;70(4):400-6.","DOI":"10.1111\/anae.13016"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Simmons ST, Schleich AR. Airway regional anesthesia for awake fiberoptic intubation. Reg Anesth Pain Med. 2002;27(2):180-92.","DOI":"10.1097\/00115550-200203000-00012"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Bramante RM, Rand M. Images in clinical medicine. Angioedema. N Engl J Med. 2011;365(2):e4.","DOI":"10.1056\/NEJMicm1014034"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Richman MJ, Talan DA, Lumry WR. Treatment of laryngeal hereditary angioedema. J Emerg Med. 2012;42(1):44-7.","DOI":"10.1016\/j.jemermed.2010.11.032"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"James C, Bernstein JA. Current and future therapies for the treatment of histamine-induced angioedema. Expert Opin Pharmacother. 2017;18(3):253-62.","DOI":"10.1080\/14656566.2017.1282461"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Simons FE, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101(1 Pt 1):33-7.","DOI":"10.1016\/S0091-6749(98)70190-3"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-3.","DOI":"10.1067\/mai.2001.119409"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Johnston SL, Unsworth J, Gompels MM. Adrenaline given outside the context of life threatening allergic reactions. BMJ. 2003;326(7389):589-90.","DOI":"10.1136\/bmj.326.7389.589"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"ECC Committee, Subcommittee and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005;112(24 Suppl):IV1-203.","DOI":"10.1542\/peds.2006-0346"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Runge JW, Martinez JC, Caravati EM, et al. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med. 1992;21(3):237-42.","DOI":"10.1016\/S0196-0644(05)80881-9"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Lin RY, Curry A, Pesola GR, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000;36(5):462-8.","DOI":"10.1016\/s0196-0644(00)43749-2"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother. 1996;30(10):1075-9.","DOI":"10.1177\/106002809603001001"},{"key":"ref119","unstructured":"Goh CL, Wong WK, Lim J. Cetirizine vs placebo in chronic idiopathic urticaria--a double-blind randomized cross-over study. Ann Acad Med Singapore. 1991;20(3):328-30."},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Finn AF Jr,\u00a0Kaplan AP,\u00a0Fretwell R, et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol.\u00a01999;104(5):1071-8.","DOI":"10.1016\/s0091-6749(99)70091-6"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Nelson HS,\u00a0Reynolds R,\u00a0Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol.\u00a02000;84(5):517-22.","DOI":"10.1016\/s1081-1206(10)62515-x"},{"key":"ref122","unstructured":"Kapp A,\u00a0Wedi B. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. J Drugs Dermatol.\u00a02004;3(6):632-9."},{"key":"ref123","unstructured":"Monroe EW,\u00a0Bernstein DI,\u00a0Fox RW, et al. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Arzneimittelforschung.\u00a01992;42(9):1119-21."},{"key":"ref124","unstructured":"Monroe EW. Relative efficacy and safety of loratidine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther. 1992;14(1):17-21."},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Handa S,\u00a0Dogra S,\u00a0Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat.\u00a02004;15(1):55-7.","DOI":"10.1080\/09546630310013450"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175-9. Review.","DOI":"10.1056\/NEJMcp011186"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Sampson HA, \u00a0Mu\u00f1oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;47(4):373-80.","DOI":"10.1016\/j.annemergmed.2006.01.018"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Pickering RJ, Good RA, Kelly JR, et al. Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lancet. 1969;1(7590):326-30.","DOI":"10.1016\/s0140-6736(69)91295-1"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Hill BJ, Thomas SH, McCabe C. Fresh frozen plasma for acute exacerbations of hereditary angioedema. Am J Emerg Med. 2004;22(7):633.","DOI":"10.1016\/j.ajem.2004.09.015"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Pekdemir M, Ersel M, Aksay E, et al. Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med. 2007;33(2):137-9.","DOI":"10.1016\/j.jemermed.2007.02.024"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Warrier MR, Copilevitz CA, Dykewicz MS, et al. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann Allergy Asthma Immunol. 2004;92(5):573-5.","DOI":"10.1016\/s1081-1206(10)61766-8"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Bolton MR, Dooley-Hash SL. Angiotensin-converting enzyme inhibitor angioedema. J Emerg Med. 2012;43(4):e261-2.","DOI":"10.1016\/j.jemermed.2011.03.029"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Prematta M, Gibbs JG, Pratt EL, et al. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol. 2007;98(4):383-8.","DOI":"10.1016\/s1081-1206(10)60886-1"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract. 2005;59(5):594-9.","DOI":"10.1111\/j.1742-1241.2005.00352.x"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Riha HM, Summers BB, Rivera JV. Novel therapies for angiotensin-converting enzyme inhibitor-induced angioedema: a systematic review of current evidence. J Emerg Med. 2017;53(5):662-79.","DOI":"10.1016\/j.jemermed.2017.05.037"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Jaffe CJ, Atkinson JP, Gelfand JA, et al. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol. 1975;55(6):386-93.","DOI":"10.1016\/0091-6749(75)90077-9"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Saeb A, Hagglund KH, Cigolle CT. Using fresh frozen plasma for acute airway angioedema to prevent intubation in the emergency department: a retrospective cohort study. Emerg Med Int. 2016;2016:6091510.","DOI":"10.1155\/2016\/6091510"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Hassen GW, Kalantari H, Parraga M, et al. Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema. J Emerg Med. 2013;44(4):764-72.","DOI":"10.1016\/j.jemermed.2012.07.055"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Karim MY, Masood A. Fresh-frozen plasma as a treatment for life threatening ACE-inhibitor angioedema. J Allergy Clin Immunol. 2002;109(2):370-1.","DOI":"10.1067\/mai.2002.121313"},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Stewart M, McGlone R. Fresh frozen plasma in the treatment of ACE inhibitor induced angioedema. BMJ Case Rep. 2012;2012. pii: bcr2012006849.","DOI":"10.1136\/bcr-2012-006849"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Lipski SM, Casimir G, Vanlommel M, et al. Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert \u00ae): about one case and review of the therapeutic arsenal. Clin Case Rep. 2015;3(2):126-30.","DOI":"10.1002\/ccr3.171"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Tharayil AM, Chanda AH, Shiekh HA, et al. Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway. Qatar Med J. 2014;2014(2):92-7.","DOI":"10.5339\/qmj.2014.15"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Shiber J. Lingual Angioedema due to ACE-Inhibitor. Trop Med Surg. 2014;2(1):161.","DOI":"10.4172\/2329-9088.1000161"},{"key":"ref144","unstructured":"Atalay E, \u00a0\u00d6zdemir  MT,\u00a0\u00c7i\u011fsar G, et al. Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death. Iran J Allergy Asthma Immunol. 2015;14(6):642-5."},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Millot I, Plancade D, Hosotte M, et al. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates. Br J Anaesth. 2012;109(5):827-9.","DOI":"10.1093\/bja\/aes371"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Henry Li H, Riedl M, Kashkin J. Update on the use of C1-esterase inhibitor replacement therapy in the acute and prophylactic treatment of hereditary angioedema. Clin Rev Allergy Immunol. 2019;56(2):207-18.","DOI":"10.1007\/s12016-018-8684-1"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Brackertz D, Kueppers F. Hereditary angioneurotic oedema. Lancet. 1973;2(7830):680.","DOI":"10.1016\/s0140-6736(73)92519-1"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161(5):714-8.","DOI":"10.1001\/archinte.161.5.714"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009;124(4):801-8.","DOI":"10.1016\/j.jaci.2009.07.017"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Craig TJ, Bewtra AK, Bahna SL, et al. C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks--final results of the I.M.P.A.C.T.2 study. Allergy. 2011;66(12):1604-11.","DOI":"10.1111\/j.1398-9995.2011.02702.x"},{"key":"ref151","doi-asserted-by":"crossref","unstructured":"Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 Inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010;363(6):513-22.","DOI":"10.1056\/NEJMoa0805538"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Riedl MA, Hurewitz DS, Levy R, et al. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012;108(1):49-53.","DOI":"10.1016\/j.anai.2011.10.017"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"Choi G, Soeters MR, Farkas H, et al. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion. 2007;47(6):1028-32.","DOI":"10.1111\/j.1537-2995.2007.01239.x"},{"key":"ref154","doi-asserted-by":"publisher","unstructured":"Zuraw B, Cicardi M, Levy RJ, et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol. 2010;126(4):821-7.","DOI":"10.1016\/j.jaci.2010.07.021"},{"key":"ref155","doi-asserted-by":"publisher","unstructured":"Riedl MA, Bernstein JA, Li H, et al. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2014;112(2):163-9.e1.","DOI":"10.1016\/j.anai.2013.12.004"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"Schneider L, Lumry W, Vegh A, et al. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol. 2007;120(2):416-22.","DOI":"10.1016\/j.jaci.2007.04.028"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"Lumry W, Li H, Schneider L, et al. Results of a repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88), a recombinant plasma kallikrein inhibitor, in patients with hereditary angioedema. Ann Allergy Asthma Immunol. 2007;98(Suppl 1):A29.","DOI":"10.1016\/j.jaci.2005.12.715"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"Levy R, McNeil D, Li H, et al. Results of a 2-stage, phase 3 pivotal trial, EDEMA3: a study of subcutaneous DX-88 (ecallantide), a plasma kallikrein inhibitor, in patients with hereditary angioedema (HAE). J Allergy Clin Immunol. 2008;121(2 Suppl 1):S231.","DOI":"10.1016\/j.jaci.2007.12.1190"},{"key":"ref159","doi-asserted-by":"publisher","unstructured":"Levy RJ, Lumry WR, McNeil DL, et al. EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(6):523-9.","DOI":"10.1016\/j.anai.2010.04.012"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"Bernstein JA,\u00a0Moellman JJ,\u00a0Collins SP,\u00a0et al. Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department. Ann Allergy Asthma Immunol.\u00a02015;114(3):245-9.","DOI":"10.1016\/j.anai.2014.12.007"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"Lewis LM, Graffeo C, Crosley P, et al. Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial. Ann Emerg Med. 2015;65(2):204-13.","DOI":"10.1016\/j.annemergmed.2014.07.014"},{"key":"ref162","doi-asserted-by":"crossref","unstructured":"Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532-41.","DOI":"10.1056\/NEJMoa0906393"},{"key":"ref163","doi-asserted-by":"publisher","unstructured":"Lumry WR, Li HH, Levy RJ, et al. Results from FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks. J Allergy Clin Immunol. 2011;127(2 Suppl):AB1.","DOI":"10.1016\/j.jaci.2011.01.004"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Bartal C, Zeldetz V, Stavi V, et al. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED. Am J Emerg Med. 2015;33(3):479.e1-3.","DOI":"10.1016\/j.ajem.2014.08.055"},{"key":"ref165","doi-asserted-by":"publisher","unstructured":"Charmillon A, Deibener J, Kaminsky P, et al. Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant. Intensive Care Med. 2014;40(6):893-4.","DOI":"10.1007\/s00134-014-3290-z"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Crooks NH, Patel J, Diwakar L, et al. Icatibant in the treatment of angiotensin-converting enzyme inhibitor-induced angioedema. Case Rep Crit Care. 2014;2014:864815.","DOI":"10.1155\/2014\/864815"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Gallitelli M, Alzetta M. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. Am J Emerg Med. 2012;30(8):1664.e1-2.","DOI":"10.1016\/j.ajem.2011.09.014"},{"key":"ref168","doi-asserted-by":"publisher","unstructured":"Mahajan H, Thynne T, Gabb GM, et al. Drug safety in Aboriginal Australians: three cases of angiotensin-converting enzyme inhibitor angioedema. Intern Med J. 2015;45(2):231-3.","DOI":"10.1111\/imj.12659"},{"key":"ref169","doi-asserted-by":"publisher","unstructured":"Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin converting enzyme inhibitors: a case series. Ann Emerg Med. 2010;56(3):278-82.","DOI":"10.1016\/j.annemergmed.2010.03.032"},{"key":"ref170","doi-asserted-by":"publisher","unstructured":"Bova M, Guilarte M, Sala-Cunill A, et al. Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med. 2015;10(3):345-50.","DOI":"10.1007\/s11739-015-1205-9"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Jacob J, Bardes I, Palom X, et al. Angiotensin converting enzyme inhibitor-induced angioedema and icatibant: a new hope. Intern Med J. 2015;45(10):1093-4.","DOI":"10.1111\/imj.12849"},{"key":"ref172","doi-asserted-by":"publisher","unstructured":"Volans A, Ferguson R. Using a bradykinin blocker in ACE inhibitor associated angioedema in the emergency department. BMJ Case Rep. 2013;2013. Pii:bcr2012008295.","DOI":"10.1136\/bcr-2012-008295"},{"key":"ref173","doi-asserted-by":"publisher","unstructured":"Bas M, Greve J,\u00a0Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372(5):418-25.","DOI":"10.1056\/nejmoa1312524"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Wilkerson RG, Martinelli AN, Oliver WD. Treatment of angioedema induced by angiotensin-converting enzyme inhibitor. J Emerg Med. 2018;55(1):132-3.","DOI":"10.1016\/j.jemermed.2018.01.048"},{"key":"ref175","doi-asserted-by":"publisher","unstructured":"Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced opper airway angioedema. J Allergy Clin Immunol Pract. 2017;5(5):1402-9.e3.","DOI":"10.1016\/j.jaip.2017.03.003"},{"key":"ref176","doi-asserted-by":"publisher","unstructured":"Straka BT, Ramirez CE, Byrd JB, et al. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. 2017;140(1):242-8.","DOI":"10.1016\/j.jaci.2016.09.051"},{"key":"ref177","doi-asserted-by":"publisher","unstructured":"Bentsianov BL, Parhiscar A, Azer M, et al. The role of fiberoptic nasopharyngoscopy in the management of the acute airway in angioneurotic edema. Laryngoscope. 2000;110(12):2016-9.","DOI":"10.1097\/00005537-200012000-00007"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Kreuz W, Rusicke E, Martinez-Saguer I, et al. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion. 2012;52(1):100-7.","DOI":"10.1111\/j.1537-2995.2011.03240.x"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Cicardi M, Bork K, Caballero T, et al. Evidence based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012;67(2):147-57.","DOI":"10.1111\/j.1398-9995.2011.02751.x"},{"key":"ref180","doi-asserted-by":"publisher","unstructured":"Wahn V, Aberer W, Eberl W, et al. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339-48.","DOI":"10.1007\/s00431-012-1726-4"},{"key":"ref181","doi-asserted-by":"publisher","unstructured":"Epstein TG, Bernstein JA. Current and emerging management options for hereditary angioedema in the US. Drugs. 2008;68(18):2561-73.","DOI":"10.2165\/0003495-200868180-00003"},{"key":"ref182","doi-asserted-by":"publisher","unstructured":"Cicardi M, Zingale LC, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164(8):910-3.","DOI":"10.1001\/archinte.164.8.910"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"Haymore BR, Yoon J, Mikita CP, et al. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol. 2008;101(5):495-9.","DOI":"10.1016\/s1081-1206(10)60288-8"},{"key":"ref184","doi-asserted-by":"publisher","unstructured":"Makani H, Messerli FH, Romero J, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012;110(3):383-91.","DOI":"10.1016\/j.amjcard.2012.03.034"}],"container-title":["Western Journal of Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:46:52Z","timestamp":1562680012000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/9cr1m7qq"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":185,"issue-title":["Western Journal of Emergency Medicine"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,7,5]]}},"URL":"https:\/\/doi.org\/10.5811\/westjem.2019.5.42650","relation":{},"ISSN":["1936-900X"],"issn-type":[{"value":"1936-900X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,2]]}}}